Physician profile
John E Scowley
NPI 1487623245
$2,972.67
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,093 · 2020: $869 · 2021: $11.54.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $414.97 | 2019-2020 | |
| Pfizer INC. | $333.75 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $244.54 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $222.23 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $176.64 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $174.61 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $160.63 | 2019 | |
| Sanofi-Aventis U.S. LLC | $146.46 | 2019-2020 | |
| Philips North America LLC | $121.67 | 2019 | |
| Amgen INC. | $110.87 | 2019 | |
| Janssen Pharmaceuticals, INC | $100.51 | 2019-2020 | |
| Novo Nordisk INC | $80.65 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $76.06 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.90 | 2019 | |
| Allergan, INC. | $59.13 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $54.96 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $50.67 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $49.06 | 2019-2020 | |
| Glaxosmithkline, LLC. | $48.77 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $36.22 | 2019-2021 | |
| Horizon Therapeutics Plc | $26.72 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $24.60 | 2019 | |
| Mylan Specialty L.P. | $23.56 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $17.98 | 2019 | |
| Circassia INC. | $16.49 | 2019 | |
| Redhill Biopharma INC. | $15.65 | 2020 | |
| Abbvie INC. | $15.55 | 2020 | |
| Lupin INC. | $15.26 | 2020 | |
| Genentech USA, INC. | $14.52 | 2019 | |
| Vanda Pharmaceuticals INC. | $14.23 | 2020 | |
| Daiichi Sankyo INC. | $14.12 | 2019 | |
| Eisai INC. | $13.54 | 2020 | |
| Amarin Pharma, INC. | $11.80 | 2020 | |
| Vertical Pharmaceuticals, LLC | $11.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Scowley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.